Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2022

Kadri S, Sboner A, Sigaras A, Roy S. Containers in Bioinformatics: Applications, Practical Considerations, and Best Practices in Molecular Pathology. J Mol Diagn. 2022;24(5):442-454.

Rajappa P, Eng KW, Bareja R, Bander ED, Yuan M, Dua A, et al. Utility of multimodality molecular profiling for pediatric patients with central nervous system tumors. Neurooncol Adv. 2022;4(1):vdac031.

Kim J, Rustam S, Mosquera JM, Randell SH, Shaykhiev R, Rendeiro AF, et al. Unsupervised discovery of tissue architecture in multiplexed imaging. Nat Methods. 2022;19(12):1653-1661.

Bruehl FK, Kim AS, Li MM, Lindeman NI, Moncur JT, Souers RJ, et al. Tiered Somatic Variant Classification Adoption Has Increased Worldwide With Some Practice Differences Based on Location and Institutional Setting. Arch Pathol Lab Med. 2022;146(7):822-832.

Zhang T, Zhang G, Chen X, Chen Z, Tan AY, Lin A, et al. Low-dose carbon monoxide suppresses metastatic progression of disseminated cancer cells. Cancer Lett. 2022;546:215831.

Lin C, Yang Q, Guo D, Xie J, Yang Y-, Chaugule S, et al. Impaired mitochondrial oxidative metabolism in skeletal progenitor cells leads to musculoskeletal disintegration. Nat Commun. 2022;13(1):6869.

Cid-Diaz T, Lodeiro AC, Duran A, Moscat J, Diaz-Meco MT. Air-liquid organotypic assays to investigate cellular crosstalk in the tumor microenvironment of cancer cells. STAR Protoc. 2022;3(3):101635.

Pillai AA, Kriss M, Al-Adra DP, Chadha RM, Cushing MM, Farsad K, et al. Coagulopathy and hemostasis management in patients undergoing liver transplantation: Defining a dynamic spectrum across phases of care. Liver Transpl. 2022;28(10):1651-1663.

Shouval R, Fein JA, Cho C, Avecilla ST, Ruiz J, Tomas AA, et al. The Simplified Comorbidity Index: a new tool for prediction of nonrelapse mortality in allo-HCT. Blood Adv. 2022;6(5):1525-1535.

Xiang G, Wang S, Chen L, Song M, Song X, Wang H, et al. UBR5 targets tumor suppressor CDC73 proteolytically to promote aggressive breast cancer. Cell Death Dis. 2022;13(5):451.